Enter Note Done
Go to previous page in this tab
Event
  • Presentation | Rethinking DART Testing: Advancing Dev Tox NAMs Through Stakeholder Dialogue
  • Engagement Session
  • Bookmark Icon
  • Advancing DART NAMs: A PMDA Perspective on Regulatory Science, Weight-of-Evidence, and Global Harmonization
  • Schedule
    Notes
  • Room 301‚ Convention Center
    Set Timezone

F. Mikashima. Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. Sponsor: C. Chen
Session and Activity Type
Main Session